BP000451-IHA-009: Recombinant H7N7 Influenza-A Virus Netherlands/219/03
Source: Baculovirus Insect Cells-derived.
Purity > 90%, by SDS-PAGE.
Immunological Activity: Western-Blot 0.1 ug-1ug per strip, ELISA 1 ug/Well.BP000446-SIV-114: Recombinant SIV p55
Source: Baculovirus Insect Cells-derived.
Purity > 90%, by SDS-PAGE and RP-HPLC.BP000445-HIV-002: Recombinant HIV-2 Protease
Source: E. coli-derived.
Predicted molecular mass: 10.7 kDa.BP000442-HIV-140: Recombinant HIV-2 Envelope
Source: E. coli-derived.
Purity > 95%, by HPLC and SDS-PAGE.
Applications: WB, ELISA.BP000441-HIV-131: Recombinant HIV-1 envelope conjugated to HIV-2 gp39
Source: E. coli-derived.
Specificity: Immunoreactive with all sera of HIV-1, HIV type O & HIV-2 infected individuals.
Purity > 95%, by HPLC and SDS-PAGE.
Applications: WB, ELISA.BP000439-HIV-001: Recombinant HIV-1 Protease
Source: E. coli-derived.BP000438-HIV-127: Recombinant HIV-1 p66 pol
Source: Baculovirus Insect Cells-derived.
Purity > 90%, by HPLC and SDS-PAGE.
Applications: WB, ELISA.BP000437-HIV-130: Recombinant HIV-1 p55 gag
Source: Baculovirus Insect Cells-derived.
Specificity: Immunoreactive with sera from HIV infected individuals.
Purity > 90%, by HPLC and SDS-PAGE.
Applications: WB, ELISA.BP000433-HIV-158: Recombinant HIV-1 gp41-gp120 Mosaic
Source: E. Coli-derived.
Purity > 95.0% by SDS-PAGE.
Specificity: Immunoreactive with all sera of HIV-I infected individuals.BP000426-HSV-225: Recombinant HSV-8 Mosaic
Source: E.coli-derived.
Specificity: Immunoreactive with sera of HSV-8 infected individuals.
Purity>95.0% by 10% PAGE.
Applications: WB, ELISA.